Nijveldt JJ, Af Buren S, Tran TA, Jussing E, et al. Feasibility of [(89)Zr]Zr-Atezolizumab Immuno-PET for PD-L1 Quantification in the Clinical Work-up of Metastatic Triple-Negative Breast Cancer. J Nucl Med 2026 Jan 29:jnumed.125.271459. doi: 10.2967/jnumed.125.271459.
PMID: 41611476